Tag: Research

Shares of Moderna Inc Spike by 30%

The company reported positive data on its early-stage human trial for a coronavirus vaccine earlier on Monday.
Following which it offered to raise $1.34 billion through a public offering
It hopes to primarily use the net proceeds of the offering to fund the manufacturing and distribution of its vaccine candidate, mRNA-1273, when necessary regulatory approvals are obtained.

BQ Star Yellow 3

Get Pro for 33% off

  • Access all features immediately
  • Datasets updated every day
  • Harness the power of granular data

Offer Ends In

Starting from $59 $39 / month

Help us improve


  • Your feedback is highly appreciated.

  • It'll take less than 60 seconds.